Expert Care, Close To Home.
APU Direct
320.259.1411
888.559.1411
Erectile Dysfunction
- A Phase III efficacy and safety study of three fixed doses of ED drug versus placebo in the treatment of male erectile dysfunction
- A Phase III, two year, long-term, open-label, flexible dose, safety extension study of ED drug in the treatment of erectile dysfunction
- A Phase III, at-home use study evaluating the efficacy and safety of escalating doses of ED drug in the treatment of patients with erectile dysfunction
- A Phase III study, evaluating the safety and efficacy of ED drug compared to another brand ED drug in the treatment of male erectile dysfunction
- Phase III study, six month, long term, open-label, flexible dose, safety extension study of ED medication in the treatment of erectile dysfunction
